SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Audre Lorde Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientAudre Lorde
Date of birth1934-02-18
IdentifiersMRN HR-ML016-SYN-TD; SSN (made up) 000-16-2937
Document date2026-11-01
AuthorNaomi Fairweather, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care survivorship visit five and a half months after right mastectomy for stage IA breast cancer, on tamoxifen. Concerns: Moving her breast cancer survivorship care to primary care, with the oncology team kept informed; mild hot flashes on tamoxifen; Wants complete information and to make her own decisions. She chose a flat closure without reconstruction and does not wish to wear an external prosthesis; she asks that this not be raised again unless she raises it. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five yearsOne tablet once dailyOral route1978-10-27activeS

Procedures

ProcedureDatesStatusEvidence
Diagnostic bilateral mammography after a self-detected right breast lump: 1.6 cm irregular mass in the upper outer right breast, BI-RADS 5; left breast normal1978-09-08 to 1978-09-08completedS
Right breast and axillary ultrasound: 1.6 cm irregular hypoechoic mass at 10 o'clock; normal axillary lymph nodes1978-09-08 to 1978-09-08completedS
Ultrasound-guided core needle biopsy of the right breast mass: invasive ductal carcinoma, grade 2; ER 90 percent, PR 60 percent, HER2 1+ (negative), Ki-67 12 percent1978-09-10 to 1978-09-10completedS
Right total mastectomy with flat closure and no reconstruction, her informed choice. Pathology: invasive ductal carcinoma 1.6 cm, grade 2, margins clear, no lymphovascular invasion; pT1c pN0(sn), stage IA. Recurrence score (21-gene assay) 141978-09-26 to 1978-09-26completedS
Right axillary sentinel lymph node biopsy at mastectomy: 0 of 2 nodes involved1978-09-26 to 1978-09-26completedS
Diagnostic mammography of the left breast one year after diagnosis: scattered fibroglandular tissue, no suspicious findings, BI-RADS 11979-09-21 to 1979-09-21completedS
Genetic counseling for hereditary breast cancer risk: pedigree taken and multigene panel testing for inherited cancer risk sent; result pending at the end of the episode1979-10-05 to 1979-10-05completedS
Cervical sampling for cytology with human papillomavirus co-testing; result pending at the end of the episode1979-10-19 to 1979-10-19completedS

Immunizations

DateVaccineStatusEvidence
1978-10-14Influenza vaccine, 1978-1979 seasoncompletedS
1972-05-06Tdap vaccinecompletedS
1979-10-19Influenza vaccine, 1979-1980 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1977Breast tumor found by a doctor, benign after about three weeks of uncertaintyD (CLM-0003)
1978Lump in the right breast found at self-examination on Labor Day, followed by a diagnosis of breast cancer and a mastectomy; she declined a breast prosthesisD (CLM-0004, CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Moving her breast cancer survivorship care to primary care, with the oncology team kept informed; mild hot flashes on tamoxifenactiveS
Wants complete information and to make her own decisions. She chose a flat closure without reconstruction and does not wish to wear an external prosthesis; she asks that this not be raised again unless she raises itactiveS

Assessment

Most recent measures: Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1979-06-29; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 on 1979-06-29; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1979-10-19; Cholesterol [Mass/volume] in Serum or Plasma 182 on 1979-10-19; Cholesterol in HDL [Mass/volume] in Serum or Plasma 64 on 1979-10-19; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 98 on 1979-10-19; Triglyceride [Mass/volume] in Serum or Plasma 100 on 1979-10-19; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1979-10-19; Total score [AUDIT-C] 1 on 1979-10-19 [S]

Strengths and supports: Supports: her family and a wide circle of writers and friends [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the upper outer quadrant of the right breast, stage IA (pT1c pN0(sn) M0), grade 2, estrogen and progesterone receptor positive, HER2 negative, recurrence score 14; treated by right total mastectomy with sentinel node biopsy and on adjuvant tamoxifen; synthetic modern counterpart of the documented 1931 breast cancer and mastectomyactiveconfirmed C50.411S — Synthetic tumor details and treatment; the diagnosis and the mastectomy are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 90 percent, PR 60 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
Absence of the right breast after mastectomy with flat closure; she chose not to have reconstruction and not to wear an external prosthesisactiveconfirmed Z90.11S — Synthetic coding of the documented mastectomy; the decision about a prosthesis echoes her documented choice and is respected as her own.
Long-term use of tamoxifen as adjuvant endocrine therapyactiveconfirmed Z79.810S — Synthetic treatment status.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1979-03-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1979-03-09Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S
1979-06-29Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1979-06-29Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]2{score}S
1979-09-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1979-10-19Cholesterol [Mass/volume] in Serum or Plasma182mg/dL<=199 mg/dLNormalS
1979-10-19Cholesterol in HDL [Mass/volume] in Serum or Plasma64mg/dL>=50 mg/dLNormalS
1979-10-19Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation98mg/dL<=99 mg/dLNormalS
1979-10-19Triglyceride [Mass/volume] in Serum or Plasma100mg/dL<=149 mg/dLNormalS
1979-10-19Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
1979-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1979-10-19Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1979-03-09Body height168cmS
1979-03-09Body weight72kgS
1979-03-09Body mass index (BMI) [Ratio]25.5kg/m2S
1979-03-09Systolic blood pressure124mm[Hg]S
1979-03-09Diastolic blood pressure78mm[Hg]S
1979-03-09Heart rate74/minS
1979-03-09Respiratory rate14/minS
1979-03-09Body temperature36.7CelS
1979-03-09Oxygen saturation in Arterial blood by Pulse oximetry99%S
1979-03-30Body height168cmS
1979-03-30Body weight72.4kgS
1979-03-30Body mass index (BMI) [Ratio]25.7kg/m2S
1979-03-30Systolic blood pressure122mm[Hg]S
1979-03-30Diastolic blood pressure76mm[Hg]S
1979-03-30Heart rate72/minS
1979-03-30Respiratory rate14/minS
1979-03-30Body temperature36.6CelS
1979-03-30Oxygen saturation in Arterial blood by Pulse oximetry99%S
1979-06-29Body height168cmS
1979-06-29Body weight71.6kgS
1979-06-29Body mass index (BMI) [Ratio]25.4kg/m2S
1979-06-29Systolic blood pressure118mm[Hg]S
1979-06-29Diastolic blood pressure74mm[Hg]S
1979-06-29Heart rate70/minS
1979-06-29Respiratory rate14/minS
1979-06-29Body temperature36.7CelS
1979-06-29Oxygen saturation in Arterial blood by Pulse oximetry99%S
1979-09-28Body height168cmS
1979-09-28Body weight71.8kgS
1979-09-28Body mass index (BMI) [Ratio]25.4kg/m2S
1979-09-28Systolic blood pressure120mm[Hg]S
1979-09-28Diastolic blood pressure76mm[Hg]S
1979-09-28Heart rate72/minS
1979-09-28Respiratory rate14/minS
1979-09-28Body temperature36.6CelS
1979-09-28Oxygen saturation in Arterial blood by Pulse oximetry99%S
1979-10-19Body height168cmS
1979-10-19Body weight71.5kgS
1979-10-19Body mass index (BMI) [Ratio]25.3kg/m2S
1979-10-19Systolic blood pressure118mm[Hg]S
1979-10-19Diastolic blood pressure74mm[Hg]S
1979-10-19Heart rate70/minS
1979-10-19Respiratory rate14/minS
1979-10-19Body temperature36.6CelS
1979-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
1979-03-09Primary care survivorship visit five and a half months after right mastectomy for stage IA breast cancer, on tamoxifenfinishedS
1979-03-30Survivorship follow-up on the day of the medical oncology consultationfinishedS
1979-06-29Three-month survivorship visit on tamoxifenfinishedS
1979-09-28Survivorship visit one year after diagnosis, after the yearly mammogram of the left breastfinishedS
1979-10-19Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Medical oncology consultation to confirm the adjuvant endocrine therapy plan, advise on hot flashes, set the surveillance plan, and advise on genetic assessmentcompletedGL-NCCN-BREAST-2025, GL-ASCO-ENDO-2019S
Tamoxifen 20 mg daily for at least five years, with questions at every visit about hot flashes, abnormal vaginal bleeding, and leg swelling or breathlessness, and a yearly gynecologic assessmentcompletedGL-ASCO-ENDO-2019, GL-CMID-2026S
Cancer-related history and examination every 3 to 6 months for the first 3 years and a yearly diagnostic mammogram of the left breast; no routine blood tests, tumor markers, or body imaging while she has no symptomscompletedGL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013S
Germline genetic counseling and multigene panel testing for breast cancer diagnosed at 44completedGL-ASCO-SSO-GERM-2024, GL-NCCN-BREAST-2025S
Lymphedema risk counseling and arm checks at every visit; bone health by calcium and vitamin D from diet and weight-bearing exercise; distress, depression, and anxiety screening at intervalscompletedGL-ACS-ASCO-SURV-2016, GL-CMID-2026S
Written survivorship care plan, at least 150 minutes of activity a week, alcohol at or below one drink a day, and her decisions about reconstruction and a prosthesis recorded and respectedcompletedGL-ACS-ASCO-SURV-2016, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Continue tamoxifen daily with side effects she finds tolerable1979-09-28completedTaking it daily; mild hot flashes controlled without medicine; no abnormal bleeding or clot symptomsS
Complete the yearly surveillance mammogram of the left breast1979-09-28completedLeft mammogram one year after diagnosis: BI-RADS 1S
Complete germline genetic assessment, missed at diagnosis1979-10-19activeGenetic counseling completed and panel testing sent; result pendingS
Keep at least 150 minutes of activity a week and a stable weight1979-09-28completedWalking about 200 minutes a week; weight stable at 71 to 72 kgS

Functional Status

Mental Status